Primary care at the forefront of colorectal cancer screening

Similar documents
GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION

Practical challenges in establishing and running the Czech national colorectal cancer screening programme

Czech CRC screening program at the point of switch to the population based design

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.

INTERACTION WITH SCREENEES AND PATIENT ORGANIZATIONS

Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients

Bowel cancer screening and prevention

The choice of methods for Colorectal Cancer Screening; The Dutch experience

Implementing of Population-based FOBT Screening

Dr Alasdair Patrick. Dr Nagham Al-Mozany. 9:45-10:10 Where Are We Up To With Bowel Cancer Screening?

COLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE

FECAL OCCULT BLOOD TEST (FOBT) Common Guaiac versus Immunochemical Test

Measuring performance and quality indicators of CRC screening

FIT Overview. Objectives 6/23/2014

Screening for GI Cancer Past Present and Future. Prof. Bob Steele University of Dundee

Colorectal cancer screening

Challenges for Colorectal Cancer Screening

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy

Faecal testing in colorectal cancer screening: State of the Art. Prof Stephen P. Halloran

Reflections on the EUnetHTA CRC screening full Core Model pilot 1

Bowel Cancer Screening Exploiting science brings better medicine

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program

Optimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial

Global colorectal cancer screening appropriate or practical? Graeme P Young, Flinders University WCC, Melbourne

Be it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT

Implementation of Faecal Immunochemical Testing as the screening test for Bowel Screening. Programme in Wales

Risk assessment tools for the symptomatic population Graham Radford-Smith Department of Gastroenterology and Hepatology Royal Brisbane and Women s

EVALUATION OF QUANTITATIVE DETECTION OF FECAL HUMAN HAEMOGLOBIN FOR COLORECTAL CANCER SCREENING

Colorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users

North West London Pathology. Faecal Occult Blood testing. Mrs Sophie Barnes FRCPath Consultant Clinical Scientist

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016

COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST

NHS Bowel Cancer Screening Programmes: Evaluation of pilot of Faecal Immunochemical Test : Final report.

CRC screening from the viewpoint of its clients and patients results of survey

Colorectal cancer screening in England

Bowel Cancer Prevention and Screening. Harriet Wynne, Cancer Council Victoria

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

Monitoring of equity in access to CRC screening and CRC care: two sides of the same coin

Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018

Performance of Colorectal cancer screening in the European Union Member States Data from the second European screening report

ADENOMA SURVEILLANCE BCSP Guidance Note No 1 Version 1 September 2009

Colorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Programme September 2017 Prague, Czech Republic

Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests

EU Guidelines for quality assurance in organization, implementation and monitoring of colorectal cancer screening programme. Jožica Maučec Zakotnik

Financial Disclosers

Colorectal Cancer Screening State of the art in Eastern Europe. Mārcis Leja Prague, September 27, 2017

Give Yourself the All Clear Colorectal Cancer Prevention and Screening: What YOU Need to Know

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

The Dutch bowel cancer screening program Relevant lessions for Ontario

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West

Engaging Primary Care in bowel screening

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan.

On-going and planned colorectal cancer clinical outcome analyses

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist

ColonCancerCheck & Regional Updates. Cheryl Shoemaker RN, BScN, CON(C) March 19, 2014

Bowel Cancer Screening

Emerging Interventions in Endoscopy. Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital

Colorectal Cancer Screening. Paul Berg MD

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine

Health Professional Information

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE

IARC Handbook Volume 17: Colorectal Cancer Screening. Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M

Why FIT (Faecal Immunochemical Test) is the best biomarker for CRC screening

Are you ready for the Colorectal Cancer Screening Pilot Programme?

Transition to Fecal Immunochemical Testing (FIT)

NATIONAL SCREENING COMMITTEE

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers

The burden of Colorectal Cancer in Asia. Dr Saunthari Somasundaram

National Bowel Screening Programme. Quick Guide

Supplementary Online Content

ENGAGING PRIMARY CARE IN BOWEL SCREENING

Transforming Cancer Services for London

Cologuard Screening for Colorectal Cancer

HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation

Risk scoring incorporating FIT in triage of symptomatic patients

CANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital

Programme Report Round One

Efficacy, effectiveness, quality: sources of data

Cost-effectiveness analysis of a screening programme. Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam

Updates in Colorectal Cancer Screening & Prevention

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)

Prevention and management of cancer in primary care. Presentation + interactive discussion with DoHA 11am Wednesday November 7 th 2012

Colon Cancer Screening. A Provider Opinion Survey

Screening for Colorectal Cancer

Practice Based Research at UC San Diego Family Medicine

05/07/2018. Organisation. The English screening programme what is happening? Organisation. Bowel cancer screening in the UK is:

TPMG experience in improving colorectal cancer screening rates

ColonCancerCheck (CCC): Modelling FOBT screening in Ontario for colorectal cancer (CRC) using the Cancer Risk Management Model (CRMM)

UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography

Transcription:

Primary care at the forefront of colorectal cancer screening Presentation by Bohumil Seifert Department of General Practice, 1st Faculy of Medicine, Charles University in Prague 04/05/2012

Introduction Prague 1.7.2000 Institute of General Practice, Prague Training practice 2 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Special interest in colorectal cancer screning A member of a Foundation which initiated colorectal cancer screening in the Czech Republic in 2000 Representative of GPs in Czech National Colorectal Cancer Screening Committee Education for GPs and public on CRC screening Research on - the role of primary care physicians in screening - attitudes toward screening in target population - FOBT methods 3 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Characteristics of the medicine in the 3rd millenium Key issue: Non-communicable diseases Fascinating technology development Succeses in diagnostics and treatment and improvement of prognosis of serious diseases Successes and expectations push medicine towards prevention towards pro-active inteventions in asymptomatic people 4 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Prevention and screening Consequencies: Ethics (nature of patient doctor relation) Safety Costs Capacity 5 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Colorectal cancer is the most preventable visceral form of cancer Stage of diagnosis matters! Early diagnostics helps to increase 5-year survival: Duke s A (90%) v. stage with distant metastases ( 10%) Colorectal cancer is preventable before exists. Identification and excision of risk polyps About half of polyps/cancers bleed and blood can be detected by simple test. Colonoscopy is a method with high diagnostic and curable capacity 6 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Early diagnostics of colorectal cancer The principal method of identification of colorectal cancer stays symptomatic presentation to GPs who are source of referral to secondary care. 90% of colorectal cancers detected Importance of research on early diagnostics 7 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Early diagnostics of colorectal cancer GP Competence Interdisciplinary cooperation Referral system Capacity Access to colonoscopy, waiting times Prioritization Research: -on sensitivity, specificity, PPV of symptoms -on markers (ifob, M2-PK, calprotectin stool test) 8 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Role of primary care in prevention Primary prevention Secondary prevention: -screening programmes for high risk persons -screening programmes for average risk p. Early diagnosis in symptomatic Quality of care/tertiary prevention 9 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

CRC screening: Implications for General Practice The involvement of GPs varies in countries according to The involvement of GPs varies in countries according to chosen strategy: chosen strategy: Direct: performing FOBT (CR, SLO, GER) Direct: performing FOBT (CR, SLO, GER) Indirect: recruitment for colonoscopy screening (Pol) Indirect: recruitment for colonoscopy screening (Pol) Supportive: administrative, advices (UK) Supportive: administrative, advices (UK) The involvement of people Population The involvement based screening of people (central invitation UK) Organized screening (GP/patient activities,ge,czech) Opportunistic screening (Poland) Population based screening (central invitation UK) Organized screening (GP/patient activities,ge,czech) Opportunistic screening (Poland) Lionis C. Colorectal cancer screening and the challenging role of general practitioner/ family physician: an issue of quality, Quality in Primary Care 2007; 15:129-31 Seifert B., The role of primary care in colorectal cancer screening: The experience from the Czech Republic, Neoplasma, 2008; 55:74-80 10 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Benefits of primary care involvement in screening program complex approach to person personalised care additional value of preventive/screening programs (CV, GYN, MAM, CRC) cheaper 11 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Burden of screening program in primary care Workload (up to 300 FOBT per year per practice) Organization issues Ethics Bad news 12 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

What matters the most in screening? If we put money in colorectal cancer screening what affects the most the outcomes? 1. Adherence rate? 2. Choice of primary test? 3. Quality/capacity of endoscopic services? 4. Program monitoring /data collection? 13 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

1. Adherence rate 14 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Population based v. organized screening Programs using invitation system show higher adherence of target population Central invitiation is the only way how to get participation over 50%. Invitation via GP offices increases the adherence rate in 8% (UK) CZECH PROGRAM: letters administered by sick funds (different for all three programs) will invite people to GPs (gynaecologists, mamma centrum) since 2013. 15 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

1. Choice of primary test 16 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

European guidelines: FOBT Dietary restriction is not indicated for programmes using either guaiac-based or immunochemical tests Drug restriction is not recommended for population screening programmes using either guaiac-based or immunochemical test The ifobt is preferable over gfobt (higher participation, smaller number of stool samples needed, automated reading, greater sensitivity for detection of advanced adenomas, similar PPV)

Optimal FOBT Without diet restriction Simple (user friendly) quantitative sampling Easy logistics (POCT?) Automatic reading Cut off options with regards to - optimal sensitivity and specificity - safety, capacity and cost/benefit - risk groups (men, seniors, diabetics) Quantitative ifob tests 18 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

FOBT: Cut off optimalization CUT OFF high low Number of colonoscopies Sensitivity Specificity PPV Chen, 2007: Rossum, 2009: 100 150ng/ml faecal hemoglobin 75 ng/ml for the Netherland 200ng/ml where CS capacity is insuff. Recent Czech study shows, that suggested cut off 75ng/ml would mean FOBT positivity rate 12-16% compare to current 4% with gfobt. 19 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

4. Program monitoring/data collection? 20 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Data collection Epidemiology: incidence prevalence mortality staging 5 years survival Quality of life Outcomes, Efficiency, Screening: FOBT PS colonoscopy S colonoscopy Follow up Diagnostics Treatment Costs, Capacity Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Primary care data: Effect of measures for improvement centrally collected (hard) data/indicators: - FOBT adherence rate - FOBT positivity rate - GPs, gynaecologists involvement - regional differencies primary care collected data (experimentally) - waiting times for colonoscopies - compliance with colonoscopy in FOBT positives - feedback on endoscopic services/adherence to guidelines Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Colorectal Cancer: Imperatives for primary care Do not miss a symptomatic cancer/refer in time! Identify high risk patients! Screen for colorectal cancer! 23 Primary care at the forefront of colorectal cancer screening. Presentation by Bohumil Seifert

Thank you for attending, if you are interested in finding out more about UEG visit www.ueg.eu Like us on Facebook at www.facebook.com/ueg Tweet us on @ueg Presentation by Bohumil Seifert Department of General Practice, 1st Faculy of Medicine, Charles University in Prague 17/05/2012